EUVIMEDEUVIMED entdecken
Crossref

NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1

Zhiheng Zhang, Bojiao Song, Haowei Wei, Yang Liu, Wenjie Zhang, Yuhong Yang, Beicheng Sun

Drug Resistance Updates · 2024

DOI: 10.1016/j.drup.2023.101040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2024. Verfasst von Zhiheng Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University & Department of Hepatobiliary Surgery, Nanjing Drum To…. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsAnimalsHumansMiceCell Line, TumorDisease Models, AnimalHistocompatibility Antigens Class IImmunotherapyTumor MicroenvironmentN-myc Downstream-Regulated Gene 1 ProteinMembrane ProteinsVesicular Transport ProteinsAutophagy-Related Proteins

Stichwörter der Autor:innen

Autophagy-related 9ADrug resistanceImmunotherapyMajor histocompatibility complex-1N-myc downstream-regulated gene 1Pancreatic ductal adenocarcinoma

Substanzen

Histocompatibility Antigens Class IN-myc Downstream-Regulated Gene 1 ProteinATG9A protein, humanMembrane ProteinsVesicular Transport ProteinsAutophagy-Related Proteins

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University & Department of Hepatobiliary Surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicin…
  • Department of Hepatobiliary Surgery, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, Jiangsu, China.
  • Department of Endocrinology and Metabolism, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. Electronic address: yangyuhong@126.com.

Zitieren

APA

Zhang, Z., Song, B., Wei, H., Liu, Y., Zhang, W., Yang, Y., & Sun, B. (2024). NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2023.101040

Vancouver

Zhang Z, Song B, Wei H, Liu Y, Zhang W, Yang Y, et al. NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1. Drug Resistance Updates. 2024. doi:10.1016/j.drup.2023.101040

BibTeX
@article{Zhang2024,
  author = {Zhang, Zhiheng and Song, Bojiao and Wei, Haowei and Liu, Yang and Zhang, Wenjie and Yang, Yuhong and Sun, Beicheng},
  title = {NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1},
  journal = {Drug Resistance Updates},
  year = {2024},
  doi = {10.1016/j.drup.2023.101040}
}
Kostenlos starten →